Archives of Medical Research
Volume 40, Issue 7 , Pages 612-617 , October 2009

Human Parvovirus B19 Infection in Patients with Coronary Atherosclerosis

  • Shih-Chi Liu

      Affiliations

    • Division of Cardiology, Min-Sheng Hospital, Tao-Yuan, Taiwan
    • These authors contributed equally to this work.
    • ,
  • Chia-Ti Tsai

      Affiliations

    • Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
    • These authors contributed equally to this work.
    • ,
  • Cho-Kai Wu

      Affiliations

    • Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Internal Medicine, National Taiwan University College of Medicine Yun-Lin Branch, Yun-Lin, Taiwan
    • ,
  • Meng-Fen Yu

      Affiliations

    • Chang Gung Institute of Technology, Kwei-Shan Tao-Yuan, Taiwan
    • ,
  • Mu-Zon Wu

      Affiliations

    • Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Liang-In Lin

      Affiliations

    • Department of Medical Technology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Shoei-Shen Wang

      Affiliations

    • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Juey-Jen Hwang

      Affiliations

    • Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Yung-Zu Tseng

      Affiliations

    • Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Fu-Tien Chiang

      Affiliations

    • Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Chuen-Den Tseng

      Affiliations

    • Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
    • Corresponding Author InformationAddress reprint requests to: Dr. Chuen-Den Tseng, Department of Internal Medicine, National Taiwan University Medical College, No. 7, Chung-Shan South Road, Taipei, Taiwan; Phone: 886-2-23123456, ext. 3951; FAX: 886-2-23935346

Received 27 April 2009 ,Accepted 31 August 2009.

References 

  1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet. 1997;350:430–436
  2. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095–4103
  3. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100:e20–e28
  4. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126
  5. Prasad A, Zhu J, Halcox JPJ, et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation. 2002;106:184–190
  6. Török TJ. Parvovirus B19 and human disease. Adv Intern Med. 1992;37:431–455
  7. Brown KE, Young NS. Parvovirus B19 infection and hematopoiesis. Blood Rev. 1995;9:176–182
  8. Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis. 2000;59:672–683
  9. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15:485–505
  10. Takahashi M, Ito M, Sakamoto F, et al. Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol. 1995;22:168–172
  11. Nakazawa T, Tomosugi N, Sakamoto K, et al. Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis. 2000;35:E31
  12. Finkel TH, Török TJ, Ferguson PJ, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?. Lancet. 1994;343:1255–1258
  13. Harel L, Straussberg R, Rudich H, et al. Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes. Clin Infect Dis. 2000;30:500–503
  14. Dingli D, Pfizenmaier DH, Arromdee E, et al. Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet. 2000;356:312–314
  15. Murer L, Zacchello G, Bianchi D, et al. Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation. J Am Soc Nephrol. 2000;11:1132–1137
  16. Bultmann BD, Klingel K, Sotlar K, et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol. 2003;34:92–95
  17. Sloots T, Devine PL. Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19. Eur J Clin Microbiol Infect Dis. 1996;15:758–761
  18. Long AA, Komminoth P, Lee E, et al. Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections: detection of viral DNA, gene rearrangements and chromosomal translocations. Histochemistry. 1993;99:151–162
  19. Nuovo GJ. Detection of viral infections by in situ PCR: theoretical considerations and possible value in diagnostic pathology. J Clin Lab Anal. 1996;10:335–349
  20. Yin J, Kaplitt MG, Kwong AD, et al. In situ PCR for in vivo detection of foreign genes transferred into rat brain. Brain Res. 1998;783:347–354
  21. Hemauer A, von Poblotzki A, Gigler A, et al. Sequence variability among different pavovirus B19 isolates. J Gen Virol. 1996;77:1781–1785
  22. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med. 1995;1:1274–1278
  23. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the Council on Atherosclerosis, American Heart Association. Circulation. 1995;92:1355–1374
  24. Lin KH, You SL, Chen CJ, et al. Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol. 1999;57:169–173
  25. Heegaard ED, Petersen BL, Heilmann CJ, et al. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J ClinMicrobiol. 2002;40:933–936
  26. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. 1988;25:151–153
  27. Kerr JR, Barah F, Mattey DL, et al. Circulating tumour necrosis factor-α and interferon-γ are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol. 2001;82:3011–3019
  28. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993;262:114–117
  29. Thomas M, Wong Y, Thomas D, et al. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation. 1999;99:2733–2736
  30. Vink A, Poppen M, Schoneveld AH, et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation. 2001;103:1613–1617

PII: S0188-4409(09)00152-0

doi: 10.1016/j.arcmed.2009.09.002

Archives of Medical Research
Volume 40, Issue 7 , Pages 612-617 , October 2009

Article Tools

* Image Usage & Resolution